-
4D Molecular Therapeutics' (FDMT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings
ソース: Buzz FX / 20 1 2025 18:55:17 America/New_York
4D Molecular Therapeutics' (FDMT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings Written by MarketBeat January 20, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics ( NASDAQ:FDMT - Get Free Report ) 's stock had its "sell (d-)"
Read more...